Singapore-MIT Alliance for Research and Technology (SMART) researchers have developed a new lab-free immune profiling assay that can be used “to better profile aggressive, rapidly changing host immune response in cases of infection, for example COVID-19,” reports HealthCare Asia Daily.
A new assay developed by researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research Group (IRG) at the Singapore-MIT Alliance for Research and Technology (SMART), can profile the “rapidly changing host immune response in case of infection, in a departure from existing methods that focus on detecting the pathogens themselves,” reports the Scientific Inquirer.
Forbes contributor Jack Kelly spotlights Ginger, an MIT startup that has created “a smartphone-based technology app helps identify patterns of anxiety, stress and depression.”
Boston Globe reporter Andy Rosen writes that the Broad Institute of MIT and Harvard has launched “a new, $300 million initiative that applies advanced computer science to some of the hardest problems in medicine — an endeavor it said could uncover new ways to fight cancer, infectious disease, and other illnesses.”
Prof. Gio Traverso speaks with CNN’s Jeanne Moos about his new study examining how comfortable patients were interacting with Dr. Spot, a robotic dog outfitted with a computer tablet that allows ER doctors to engage with patients remotely. “The robot looks like a dog, and dogs are endearing to many, so actually, the reception was very positive,” said Traverso.
NY Post reporter Asia Grace writes that MIT researchers have found that patients are comfortable with allowing robotic assistants perform medical evaluations, as part of an effort to help reduce the spread of Covid-19. “People are very positive and accepting of robotic systems in health-care settings, particularly during the pandemic,” says Prof. Giovanni Traverso.
Writing for The New York Times, Prof. Amy Finkelstein emphasizes the effectiveness of randomized clinical trials. Finkelstein notes that she hopes “truly rigorous testing of social policy will become as commonplace as it is for new vaccines. That would help ensure that government services are delivered as effectively and efficiently as possible.”
"You remember when we go to election polls, the voting booth, during elections, we get a little sticker that says 'I Voted'" says Prof. Sinan Aral of a new study that finds hearing about people who have received the Covid-19 vaccine can increase vaccine acceptance rates. "You should think of this as a very similar type of strategy. The reason we get that sticker that says 'I Voted' is that social proof motivates people to join in. And so if we got a sticker or put out a video or put out a message that said, 'I got vaccinated,' it would have the same effect for the same reasons."
Research scientist Andreas Mershin speaks with Noam Hassenfeld of Vox about his work developing a new AI system that could be used to detect disease using smell.
AP reporter Jake Goodrick spotlights alumnus John Mansell’s commitment to advancing treatments aimed at reducing pain. His goal is to anything we can do to reduce suffering,” Mansell says. “What we’re doing here is trying to take mechanisms that fight where your body overdoes it.”
A new AI-powered system developed by researchers from MIT and other institutions can detect prostate cancer in urine samples as accurately as dogs can, reports Tanya Lewis and Prachi Patel for Scientific American. “We found we could repeat the training you use for dogs on the machines until we can’t tell the difference between the two,” says research scientist Andreas Mershin.
ITV reporter Liz Summers spotlights how researchers from MIT and other institutions have developed a new system that could eventually be used to help detect diseases via smell. The researchers hope the results could “eventually result in the production of a ‘robotic nose’ perhaps in the form of a smartphone app.”
UPI reporter Brian P. Dunleavy writes that MIT researchers have developed a new system, modeled on a dog’s keen sense of smell, that could be used to help detect disease using smell. “We see the dogs and their training research as teaching our machine learning [sense of smell] and artificial intelligence algorithms how to operate,” says research scientist Andreas Mershin.
A team of researchers from MIT and other institutions have created a new sensor that could be used to sniff out disease, reports Charlie Jones for the BBC. Research scientist Andreas Mershin says "Imagine a day when smartphones can send an alert for potentially being at risk for highly aggressive prostate cancer, years before a doctor notices a rise in PSA levels.”
Fast Company reporter Ruth Reader writes that researchers from MIT and other institutions have developed a new miniaturized detector that could be used to detect diseases by smell. “This paper was about integrating all the techniques that we know can work independently and finding out what of all this can go and become [part of] an integrated smartphone-based diagnostic,” says research scientist Andreas Mershin.